# IPCA Laboratories Ltd (IPCALAB)

NSE equity · series EQ · Pharmaceuticals · Mid Cap

Data as of **2026-10-01**. End-of-day data derived from NSE bhavcopy. Historical prices are adjusted for splits and bonuses.

## Latest session

| Field | Value |
| --- | --- |
| Close | ₹1,943.2 |
| Change | 16.2 (+0.84%) |
| Open / High / Low | 1,929.9 / 1,966.8 / 1,880.8 |
| Volume | 3,23,967 |
| Delivery | 57.47% |
| VWAP | 1,941.9 |
| 52-week high / low | 2,009.6 / 1,268.7 |
| From 52-week high | -3.30% |
| Market cap | ₹37,111.85 crore |

## Returns

| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD |
| --- | --- | --- | --- | --- | --- | --- | --- |
| -2.70% | -2.23% | +14.55% | +28.84% | +46.40% | +107.68% | +1182.81% | +36.95% |

## Last 10 sessions

| Date | Open | High | Low | Close | Volume | Delivery % |
| --- | --- | --- | --- | --- | --- | --- |
| 2026-10-01 | 1,929.9 | 1,966.8 | 1,880.8 | 1,943.2 | 3,23,967 | 57.47 |
| 2026-09-30 | 1,950.3 | 1,984.9 | 1,916.4 | 1,927 | 3,12,460 | 61.24 |
| 2026-09-29 | 1,919.7 | 1,980 | 1,919.7 | 1,938.1 | 2,46,042 | 49.46 |
| 2026-09-28 | 1,956 | 1,972.9 | 1,902.3 | 1,919.3 | 1,70,123 | 63.51 |
| 2026-09-25 | 2,020 | 2,020 | 1,950 | 1,970.8 | 2,63,825 | 55.08 |
| 2026-09-24 | 1,968.9 | 2,006.9 | 1,962.6 | 1,997.1 | 2,72,964 | 37.04 |
| 2026-09-23 | 1,993 | 1,999.4 | 1,948.5 | 1,962.6 | 1,59,445 | 51.51 |
| 2026-09-22 | 2,015.5 | 2,037 | 1,980 | 1,992.4 | 1,22,345 | 63.68 |
| 2026-09-21 | 2,012 | 2,033.9 | 2,000.8 | 2,008.2 | 1,73,299 | 61.01 |
| 2026-09-18 | 1,972.3 | 2,038 | 1,964 | 2,009.6 | 5,27,501 | 68.56 |

## Corporate actions

| Ex-date | Type | Detail |
| --- | --- | --- |
| 2022-01-10 | SUBDIVISION | Face Value Split (Sub-Division) - From Rs 2/- Per Share To Re 1/- Per Share |

## More data

- JSON with one year of daily history: https://bhavcopy.live/agents/stocks/IPCALAB.json
- Full history (compact app format, see /llms.txt): https://bhavcopy.live/market_data/equity-details/IPCALAB.json
- Market overview: https://bhavcopy.live/agents/market.md

_For information only. Not investment advice. Verify with the exchange before acting on this data._